Research progress on the etiopathogenesis of statin-induced myopathy
Pku Daxin
Abstract
Pku Daxin
Abstract
Statins is inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A(HMG-CoA) reductase,which is mainly used for meliorating the lipid pro?le of hyperlipemic and cardiovascular disease and is the most extensively used blood-lipid lowering drug clinically at present.Currently,the side effects of statins have been calling people's attention and increasing studies are carried out on the mechanisms of statin-induced myopathy.In this review we focus on the etiopathogenesis of statin-induced myopathy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Statins is inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A(HMG-CoA) reductase,which is mainly used for meliorating the lipid pro?le of hyperlipemic and cardiovascular disease and is the most extensively used blood-lipid lowering drug clinically at present.Currently,the side effects of statins have been calling people's attention and increasing studies are carried out on the mechanisms of statin-induced myopathy.In this review we focus on the etiopathogenesis of statin-induced myopathy.
Key concepts: Myopathy, Statin, Medicine, Hydroxymethylglutaryl-CoA Reductase Inhibitors, HMG-CoA reductase, Coenzyme A, Drug, Reductase